Ranked by engagement
Top topics — all time page 37
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 37 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold?
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022)…
|
+19 | 23 | 4.2k | 19mo |
|
Why I now write the concentration on the vial in marker
Asking directly, because I could not find a straight answer: Why I now write the concentration on the vial in marker Practical question with the units stated, because I have seen how quickly these go wrong…
|
+1 | 5 | 30k | 11d |
|
Titrating on tolerability rather than on the calendar
On the subject in the title: Titrating on tolerability rather than on the calendar Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking rather…
|
2 | 31k | 13mo | |
|
Specification in the result column: why that is a meaningful error — the long version
Specification in the result column: why that is a meaningful error — the long version Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I…
|
+14 | 18 | 12k | 17mo |
|
Appeal templates and why they are deliberately unemotional
Posting this under the heading it deserves: Appeal templates and why they are deliberately unemotional Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…
|
+25 | 29 | 764 | 7mo |
|
[2026 update] Documenting an adverse event properly
Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published trials in this…
|
+18 | 22 | 4.3k | 1d |
|
Early satiety becoming a problem rather than a benefit
Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same thing…
|
+20 | 24 | 2.5k | 6mo |
|
[2026 update] Heterogeneity as information rather than as a nuisance
Heterogeneity as information rather than as a nuisance Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I…
|
4 | 32k | 11mo | |
|
Substitution between formats during a shortage — what changed since
Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+17 | 21 | 2.7k | 9d |
|
Talking to a therapist about this specifically
Posting this under the heading it deserves: Talking to a therapist about this specifically Everything below is what sits behind that. Asking about a population rather than about a person. The published trials…
|
+20 | 24 | 855 | 14h |
|
About the Pharmacokinetics category
Half-life, accumulation, steady state, albumin binding, and why weekly dosing works. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 32k | 8mo | |
|
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med ,…
|
+18 | 22 | 656 | 13h |
|
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold?
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing STEP 1 ( N Engl J Med ,…
|
3 | 28k | 6mo | |
|
Coming back to: What consumer-accessible tests can and cannot determine
Asking directly, because I could not find a straight answer: What consumer-accessible tests can and cannot determine Posting the method first, because I know what the first three replies will otherwise be.…
|
+4 | 8 | 25k | 22mo |
|
NHS criteria and how they are applied in practice — the long version
Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A coverage question with the paperwork detail…
|
+11 | 15 | 11k | 9mo |
|
GIP receptor agonism and the argument about direction — does this still hold?
GIP receptor agonism and the argument about direction — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic…
|
+10 | 14 | 15k | 16h |
|
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
|
+4 | 8 | 23k | 8mo |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+17 | 22 | 4.5k | 1d |
|
Rewriting my first post: a before-and-after, with commentary — what changed since
Posting this under the heading it deserves: Rewriting my first post: a before-and-after, with commentary — what changed since Everything below is what sits behind that. I want to check my reasoning rather…
|
+15 | 19 | 12k | 13h |
|
Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I…
|
+16 | 20 | 3.1k | 11h |
|
Batch date after test date, and other internal inconsistencies
Batch date after test date, and other internal inconsistencies — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
|
+27 | 31 | 4.9k | 7mo |
|
[2026 update] Distinguishing expected GI effects from something that needs urgent attention
On the subject in the title: Distinguishing expected GI effects from something that needs urgent attention Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…
|
+10 | 14 | 11k | 4mo |
|
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med ,…
|
+10 | 14 | 8.4k | 16h |
|
Comparators chosen for regulatory reasons rather than clinical ones
On the subject in the title: Comparators chosen for regulatory reasons rather than clinical ones Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
2 | 27k | 14mo | |
|
Second pass at: Domestic fridge temperature mapping: a cheap experiment
Posting this under the heading it deserves: Second pass at: Domestic fridge temperature mapping: a cheap experiment Everything below is what sits behind that. I have read the maintained page on this and I…
|
2 | 30k | 16mo | |
|
[2026 update] Building a sensible monitoring schedule with your prescriber
Posting this under the heading it deserves: Building a sensible monitoring schedule with your prescriber Everything below is what sits behind that. General question, not a request for advice about my own care…
|
+22 | 26 | 5.1k | 14mo |
|
Revisiting: What to include when your question involves arithmetic
Revisiting: What to include when your question involves arithmetic — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the…
|
+21 | 25 | 384 | 12mo |
|
Second pass at: I joined for one answer and stayed for a year — what changed my mind
Second pass at: I joined for one answer and stayed for a year — what changed my mind — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have…
|
4 | 25k | 2mo | |
|
Cleaning a self-reported dataset and what you throw away
Cleaning a self-reported dataset and what you throw away — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
2 | 28k | 1d | |
|
Turnaround times and what they mean for a decision
Turnaround times and what they mean for a decision Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
4 | 29k | 3mo |